These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 17668211)

  • 1. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
    Yuvaraj S; Premkumar VG; Shanthi P; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Breast Cancer Res Treat; 2009 Mar; 114(2):377-84. PubMed ID: 18427979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
    Perumal SS; Shanthi P; Sachdanandam P
    Chem Biol Interact; 2005 Feb; 152(1):49-58. PubMed ID: 15766922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy.
    Premkumar VG; Yuvaraj S; Sathish S; Shanthi P; Sachdanandam P
    Vascul Pharmacol; 2008; 48(4-6):191-201. PubMed ID: 18407793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.
    Premkumar VG; Yuvaraj S; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):387-91. PubMed ID: 17516992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy.
    Premkumar VG; Yuvaraj S; Shanthi P; Sachdanandam P
    Br J Nutr; 2008 Dec; 100(6):1179-82. PubMed ID: 18377693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice.
    Parvez S; Tabassum H; Rehman H; Banerjee BD; Athar M; Raisuddin S
    Toxicology; 2006 Aug; 225(2-3):109-18. PubMed ID: 16797820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages.
    Kasapović J; Pejić S; Todorović A; Stojiljković V; Pajović SB
    Cell Biochem Funct; 2008 Aug; 26(6):723-30. PubMed ID: 18636415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients.
    Muralikrishnan G; Amanullah S; Basha MI; Boopalan S; Vijayakumar S; Shakeel F
    Chemotherapy; 2010; 56(4):298-302. PubMed ID: 20714147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer.
    Yeh CC; Hou MF; Tsai SM; Lin SK; Hsiao JK; Huang JC; Wang LH; Wu SH; Hou LA; Ma H; Tsai LY
    Clin Chim Acta; 2005 Nov; 361(1-2):104-11. PubMed ID: 16009358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice.
    Tabassum H; Parvez S; Rehman H; Dev Banerjee B; Siemen D; Raisuddin S
    Hum Exp Toxicol; 2007 Jun; 26(6):509-18. PubMed ID: 17698946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia.
    Ahmad R; Tripathi AK; Tripathi P; Singh R; Singh S; Singh RK
    Singapore Med J; 2010 Feb; 51(2):110-5. PubMed ID: 20358148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
    Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
    Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin E on tamoxifen-treated breast cancer cells.
    Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
    Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
    Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
    J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
    Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
    Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
    Elango N; Samuel S; Chinnakkannu P
    Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.